proteomic profiling: Clinical Trials

5 trials of proteomic profiling, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 withdrawn. 5 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Completed 4, Withdrawn 1
Phase 21Completed 1

Follow proteomic profiling: new trials by email Literature Review of proteomic profiling trials Research Report on proteomic profiling

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
ABT-888, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
temozolomide, veliparib, DNA methylation analysis - Brain and Central Nervous System Tumors
Phase 1CompletedSidney Kimmel Comprehensive Cancer Center at Johns Hopkins242009-07-132018-06-27
S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors
docetaxel, vandetanib, proteomic profiling - Breast Cancer, Head and Neck Cancer
Phase 1WithdrawnSWOG Cancer Research Network2008-09-012017-04-24
Lapatinib and Vinorelbine in Treating Patients With Advanced Solid Tumors
lapatinib ditosylate, vinorelbine ditartrate, comparative genomic hybridization - Unspecified Adult Solid Tumor, Protocol Specific
Phase 1CompletedUniversity of California, Davis222005-12-012012-04-19
Hepatic Arterial Infusion of Floxuridine, Gemcitabine Hydrochloride, and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer Previously Treated With Surgery
gemcitabine hydrochloride, floxuridine, proteomic profiling - Liver Metastases, Recurrent Colon Cancer
Phase 1 / Phase 2CompletedCity of Hope Medical Center162005-06-132026-11-03
Topical Sirolimus in Patients With Basal Cell Nevus Syndrome and in Healthy Participants
sirolimus, comparative genomic hybridization, gene expression analysis - Neoplastic Syndrome, Non-melanomatous Skin Cancer
Phase 1CompletedYale University162016-09-23

Conditions studied

Adenocarcinoma, Follicular (1)  ·  Basal Cell Nevus Syndrome (1)  ·  Breast Neoplasms (1)  ·  Breast Neoplasms, Male (1)  ·  Carcinoma, Basal Cell (1)  ·  Carcinoma, Medullary (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Central Nervous System Neoplasms (1)  ·  Colonic Neoplasms (1)  ·  Esthesioneuroblastoma, Olfactory (1)  ·  Glioblastoma (1)  ·  Gliosarcoma (1)  ·  Head and Neck Neoplasms (1)  ·  Lung Neoplasms (1)  ·  Neoplasms (1)

Sponsors

City of Hope Medical Center (1)  ·  SWOG Cancer Research Network (1)  ·  Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1)  ·  University of California, Davis (1)  ·  Yale University (1)

Countries

United States (3)

Top investigators

Allen E. Bale, MD (1)  ·  Helen K. Chew, MD (1)  ·  Jeffrey Wong (1)  ·  Larry Kleinberg, MD (1)  ·  Monica Mita, MD (1)

NIH funding

P30CA093373 (1), U01CA062475 (1)